| Counseling Solutions Of Alaska Llc | |
|
701 E Tudor Rd Suite 135 Anchorage AK 99503-7409 | |
| (907) 644-8044 | |
| (907) 644-8004 |
| Full Name | Counseling Solutions Of Alaska Llc |
|---|---|
| Speciality | Clinic/Center |
| Location | 701 E Tudor Rd, Anchorage, Alaska |
| Authorized Official Name and Position | Kathleen A Gianotti (PARTNER) |
| Authorized Official Contact | 9076448044 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Counseling Solutions Of Alaska Llc Po Box 240068 Anchorage AK 99524-0068 Ph: (907) 644-8044 | Counseling Solutions Of Alaska Llc 701 E Tudor Rd Suite 135 Anchorage AK 99503-7409 Ph: (907) 644-8044 |
| NPI Number | 1477682623 |
|---|---|
| Provider Enumeration Date | 03/05/2007 |
| Last Update Date | 03/25/2009 |
| Medicare PECOS PAC ID | 6901160027 |
|---|---|
| Medicare Enrollment ID | O20240220001553 |
News Archive
Celtaxsys, Inc., a clinical stage drug development company focused on developing novel therapies for inflammatory diseases, today announced the successful completion of a $40M Series D financing led by Domain Partners VIII. Additional investors in the financing include Lumira Capital, RMI Partners, Masters Capital Management and the Georgia Research Alliance Venture Fund.
Disasters such as floods, tsunamis, and earthquakes often result in the spread of diseases like gastroenteritis, giardiasis and even cholera because of an immediate shortage of clean drinking water. Now, chemistry researchers at McGill University have taken a key step towards making a cheap, portable, paper-based filter coated with silver nanoparticles to be used in these emergency settings.
A study appearing in this week's New England Journal of Medicine confirms that a combination of gene variants previously associated with cholesterol levels does reflect patients' cholesterol levels and can signify increased risk of heart attack, stroke or sudden cardiac death.
The emergency rooms at the CHU Sainte-Justine and The Montreal Children's Hospital of the McGill University Health Centre are seeing a significant increase in patients seeking care. The increase is due to patients with mild flu-like symptoms and fever and due to parents asking that their child be tested to determine if he has H1N1.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477682623 | NPI | - | NPPES |
| Provider Name | Jamison M Cole |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1851498554 PECOS PAC ID: 6204851371 Enrollment ID: I20051007000317 |
News Archive
Celtaxsys, Inc., a clinical stage drug development company focused on developing novel therapies for inflammatory diseases, today announced the successful completion of a $40M Series D financing led by Domain Partners VIII. Additional investors in the financing include Lumira Capital, RMI Partners, Masters Capital Management and the Georgia Research Alliance Venture Fund.
Disasters such as floods, tsunamis, and earthquakes often result in the spread of diseases like gastroenteritis, giardiasis and even cholera because of an immediate shortage of clean drinking water. Now, chemistry researchers at McGill University have taken a key step towards making a cheap, portable, paper-based filter coated with silver nanoparticles to be used in these emergency settings.
A study appearing in this week's New England Journal of Medicine confirms that a combination of gene variants previously associated with cholesterol levels does reflect patients' cholesterol levels and can signify increased risk of heart attack, stroke or sudden cardiac death.
The emergency rooms at the CHU Sainte-Justine and The Montreal Children's Hospital of the McGill University Health Centre are seeing a significant increase in patients seeking care. The increase is due to patients with mild flu-like symptoms and fever and due to parents asking that their child be tested to determine if he has H1N1.
› Verified 6 days ago
| Provider Name | Jean A Boga |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1063525145 PECOS PAC ID: 3173601952 Enrollment ID: I20080418000305 |
News Archive
Celtaxsys, Inc., a clinical stage drug development company focused on developing novel therapies for inflammatory diseases, today announced the successful completion of a $40M Series D financing led by Domain Partners VIII. Additional investors in the financing include Lumira Capital, RMI Partners, Masters Capital Management and the Georgia Research Alliance Venture Fund.
Disasters such as floods, tsunamis, and earthquakes often result in the spread of diseases like gastroenteritis, giardiasis and even cholera because of an immediate shortage of clean drinking water. Now, chemistry researchers at McGill University have taken a key step towards making a cheap, portable, paper-based filter coated with silver nanoparticles to be used in these emergency settings.
A study appearing in this week's New England Journal of Medicine confirms that a combination of gene variants previously associated with cholesterol levels does reflect patients' cholesterol levels and can signify increased risk of heart attack, stroke or sudden cardiac death.
The emergency rooms at the CHU Sainte-Justine and The Montreal Children's Hospital of the McGill University Health Centre are seeing a significant increase in patients seeking care. The increase is due to patients with mild flu-like symptoms and fever and due to parents asking that their child be tested to determine if he has H1N1.
› Verified 6 days ago
| Provider Name | Leona M Gillespie |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1134397334 PECOS PAC ID: 9830244680 Enrollment ID: I20090901000225 |
News Archive
Celtaxsys, Inc., a clinical stage drug development company focused on developing novel therapies for inflammatory diseases, today announced the successful completion of a $40M Series D financing led by Domain Partners VIII. Additional investors in the financing include Lumira Capital, RMI Partners, Masters Capital Management and the Georgia Research Alliance Venture Fund.
Disasters such as floods, tsunamis, and earthquakes often result in the spread of diseases like gastroenteritis, giardiasis and even cholera because of an immediate shortage of clean drinking water. Now, chemistry researchers at McGill University have taken a key step towards making a cheap, portable, paper-based filter coated with silver nanoparticles to be used in these emergency settings.
A study appearing in this week's New England Journal of Medicine confirms that a combination of gene variants previously associated with cholesterol levels does reflect patients' cholesterol levels and can signify increased risk of heart attack, stroke or sudden cardiac death.
The emergency rooms at the CHU Sainte-Justine and The Montreal Children's Hospital of the McGill University Health Centre are seeing a significant increase in patients seeking care. The increase is due to patients with mild flu-like symptoms and fever and due to parents asking that their child be tested to determine if he has H1N1.
› Verified 6 days ago
| Provider Name | April Nicole Savage |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1538513239 PECOS PAC ID: 5092078766 Enrollment ID: I20210624000319 |
News Archive
Celtaxsys, Inc., a clinical stage drug development company focused on developing novel therapies for inflammatory diseases, today announced the successful completion of a $40M Series D financing led by Domain Partners VIII. Additional investors in the financing include Lumira Capital, RMI Partners, Masters Capital Management and the Georgia Research Alliance Venture Fund.
Disasters such as floods, tsunamis, and earthquakes often result in the spread of diseases like gastroenteritis, giardiasis and even cholera because of an immediate shortage of clean drinking water. Now, chemistry researchers at McGill University have taken a key step towards making a cheap, portable, paper-based filter coated with silver nanoparticles to be used in these emergency settings.
A study appearing in this week's New England Journal of Medicine confirms that a combination of gene variants previously associated with cholesterol levels does reflect patients' cholesterol levels and can signify increased risk of heart attack, stroke or sudden cardiac death.
The emergency rooms at the CHU Sainte-Justine and The Montreal Children's Hospital of the McGill University Health Centre are seeing a significant increase in patients seeking care. The increase is due to patients with mild flu-like symptoms and fever and due to parents asking that their child be tested to determine if he has H1N1.
› Verified 6 days ago
| Provider Name | Rachael Rose Johnson |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1801937560 PECOS PAC ID: 3971947706 Enrollment ID: I20240220002026 |
News Archive
Celtaxsys, Inc., a clinical stage drug development company focused on developing novel therapies for inflammatory diseases, today announced the successful completion of a $40M Series D financing led by Domain Partners VIII. Additional investors in the financing include Lumira Capital, RMI Partners, Masters Capital Management and the Georgia Research Alliance Venture Fund.
Disasters such as floods, tsunamis, and earthquakes often result in the spread of diseases like gastroenteritis, giardiasis and even cholera because of an immediate shortage of clean drinking water. Now, chemistry researchers at McGill University have taken a key step towards making a cheap, portable, paper-based filter coated with silver nanoparticles to be used in these emergency settings.
A study appearing in this week's New England Journal of Medicine confirms that a combination of gene variants previously associated with cholesterol levels does reflect patients' cholesterol levels and can signify increased risk of heart attack, stroke or sudden cardiac death.
The emergency rooms at the CHU Sainte-Justine and The Montreal Children's Hospital of the McGill University Health Centre are seeing a significant increase in patients seeking care. The increase is due to patients with mild flu-like symptoms and fever and due to parents asking that their child be tested to determine if he has H1N1.
› Verified 6 days ago
| Provider Name | Dana Gordon Williams |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1487971156 PECOS PAC ID: 6002250891 Enrollment ID: I20240220003777 |
News Archive
Celtaxsys, Inc., a clinical stage drug development company focused on developing novel therapies for inflammatory diseases, today announced the successful completion of a $40M Series D financing led by Domain Partners VIII. Additional investors in the financing include Lumira Capital, RMI Partners, Masters Capital Management and the Georgia Research Alliance Venture Fund.
Disasters such as floods, tsunamis, and earthquakes often result in the spread of diseases like gastroenteritis, giardiasis and even cholera because of an immediate shortage of clean drinking water. Now, chemistry researchers at McGill University have taken a key step towards making a cheap, portable, paper-based filter coated with silver nanoparticles to be used in these emergency settings.
A study appearing in this week's New England Journal of Medicine confirms that a combination of gene variants previously associated with cholesterol levels does reflect patients' cholesterol levels and can signify increased risk of heart attack, stroke or sudden cardiac death.
The emergency rooms at the CHU Sainte-Justine and The Montreal Children's Hospital of the McGill University Health Centre are seeing a significant increase in patients seeking care. The increase is due to patients with mild flu-like symptoms and fever and due to parents asking that their child be tested to determine if he has H1N1.
› Verified 6 days ago
| Provider Name | Jennifer M Cashion |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1710103379 PECOS PAC ID: 8729422522 Enrollment ID: I20240220004197 |
News Archive
Celtaxsys, Inc., a clinical stage drug development company focused on developing novel therapies for inflammatory diseases, today announced the successful completion of a $40M Series D financing led by Domain Partners VIII. Additional investors in the financing include Lumira Capital, RMI Partners, Masters Capital Management and the Georgia Research Alliance Venture Fund.
Disasters such as floods, tsunamis, and earthquakes often result in the spread of diseases like gastroenteritis, giardiasis and even cholera because of an immediate shortage of clean drinking water. Now, chemistry researchers at McGill University have taken a key step towards making a cheap, portable, paper-based filter coated with silver nanoparticles to be used in these emergency settings.
A study appearing in this week's New England Journal of Medicine confirms that a combination of gene variants previously associated with cholesterol levels does reflect patients' cholesterol levels and can signify increased risk of heart attack, stroke or sudden cardiac death.
The emergency rooms at the CHU Sainte-Justine and The Montreal Children's Hospital of the McGill University Health Centre are seeing a significant increase in patients seeking care. The increase is due to patients with mild flu-like symptoms and fever and due to parents asking that their child be tested to determine if he has H1N1.
› Verified 6 days ago
| Provider Name | Meghan L Yarmak |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1104113067 PECOS PAC ID: 4183068828 Enrollment ID: I20240221000933 |
News Archive
Celtaxsys, Inc., a clinical stage drug development company focused on developing novel therapies for inflammatory diseases, today announced the successful completion of a $40M Series D financing led by Domain Partners VIII. Additional investors in the financing include Lumira Capital, RMI Partners, Masters Capital Management and the Georgia Research Alliance Venture Fund.
Disasters such as floods, tsunamis, and earthquakes often result in the spread of diseases like gastroenteritis, giardiasis and even cholera because of an immediate shortage of clean drinking water. Now, chemistry researchers at McGill University have taken a key step towards making a cheap, portable, paper-based filter coated with silver nanoparticles to be used in these emergency settings.
A study appearing in this week's New England Journal of Medicine confirms that a combination of gene variants previously associated with cholesterol levels does reflect patients' cholesterol levels and can signify increased risk of heart attack, stroke or sudden cardiac death.
The emergency rooms at the CHU Sainte-Justine and The Montreal Children's Hospital of the McGill University Health Centre are seeing a significant increase in patients seeking care. The increase is due to patients with mild flu-like symptoms and fever and due to parents asking that their child be tested to determine if he has H1N1.
› Verified 6 days ago
| Provider Name | Teresa J Williams |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1811213960 PECOS PAC ID: 1153765896 Enrollment ID: I20240221001034 |
News Archive
Celtaxsys, Inc., a clinical stage drug development company focused on developing novel therapies for inflammatory diseases, today announced the successful completion of a $40M Series D financing led by Domain Partners VIII. Additional investors in the financing include Lumira Capital, RMI Partners, Masters Capital Management and the Georgia Research Alliance Venture Fund.
Disasters such as floods, tsunamis, and earthquakes often result in the spread of diseases like gastroenteritis, giardiasis and even cholera because of an immediate shortage of clean drinking water. Now, chemistry researchers at McGill University have taken a key step towards making a cheap, portable, paper-based filter coated with silver nanoparticles to be used in these emergency settings.
A study appearing in this week's New England Journal of Medicine confirms that a combination of gene variants previously associated with cholesterol levels does reflect patients' cholesterol levels and can signify increased risk of heart attack, stroke or sudden cardiac death.
The emergency rooms at the CHU Sainte-Justine and The Montreal Children's Hospital of the McGill University Health Centre are seeing a significant increase in patients seeking care. The increase is due to patients with mild flu-like symptoms and fever and due to parents asking that their child be tested to determine if he has H1N1.
› Verified 6 days ago
| Provider Name | Sierra Rose Stevens |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1114062270 PECOS PAC ID: 0749624484 Enrollment ID: I20240221001163 |
News Archive
Celtaxsys, Inc., a clinical stage drug development company focused on developing novel therapies for inflammatory diseases, today announced the successful completion of a $40M Series D financing led by Domain Partners VIII. Additional investors in the financing include Lumira Capital, RMI Partners, Masters Capital Management and the Georgia Research Alliance Venture Fund.
Disasters such as floods, tsunamis, and earthquakes often result in the spread of diseases like gastroenteritis, giardiasis and even cholera because of an immediate shortage of clean drinking water. Now, chemistry researchers at McGill University have taken a key step towards making a cheap, portable, paper-based filter coated with silver nanoparticles to be used in these emergency settings.
A study appearing in this week's New England Journal of Medicine confirms that a combination of gene variants previously associated with cholesterol levels does reflect patients' cholesterol levels and can signify increased risk of heart attack, stroke or sudden cardiac death.
The emergency rooms at the CHU Sainte-Justine and The Montreal Children's Hospital of the McGill University Health Centre are seeing a significant increase in patients seeking care. The increase is due to patients with mild flu-like symptoms and fever and due to parents asking that their child be tested to determine if he has H1N1.
› Verified 6 days ago
| Provider Name | Barbara A Kolb |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1548604978 PECOS PAC ID: 2860836525 Enrollment ID: I20240221001759 |
News Archive
Celtaxsys, Inc., a clinical stage drug development company focused on developing novel therapies for inflammatory diseases, today announced the successful completion of a $40M Series D financing led by Domain Partners VIII. Additional investors in the financing include Lumira Capital, RMI Partners, Masters Capital Management and the Georgia Research Alliance Venture Fund.
Disasters such as floods, tsunamis, and earthquakes often result in the spread of diseases like gastroenteritis, giardiasis and even cholera because of an immediate shortage of clean drinking water. Now, chemistry researchers at McGill University have taken a key step towards making a cheap, portable, paper-based filter coated with silver nanoparticles to be used in these emergency settings.
A study appearing in this week's New England Journal of Medicine confirms that a combination of gene variants previously associated with cholesterol levels does reflect patients' cholesterol levels and can signify increased risk of heart attack, stroke or sudden cardiac death.
The emergency rooms at the CHU Sainte-Justine and The Montreal Children's Hospital of the McGill University Health Centre are seeing a significant increase in patients seeking care. The increase is due to patients with mild flu-like symptoms and fever and due to parents asking that their child be tested to determine if he has H1N1.
› Verified 6 days ago
| Provider Name | Stephanie Marie Palmer |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1669038691 PECOS PAC ID: 9931543642 Enrollment ID: I20240221003379 |
News Archive
Celtaxsys, Inc., a clinical stage drug development company focused on developing novel therapies for inflammatory diseases, today announced the successful completion of a $40M Series D financing led by Domain Partners VIII. Additional investors in the financing include Lumira Capital, RMI Partners, Masters Capital Management and the Georgia Research Alliance Venture Fund.
Disasters such as floods, tsunamis, and earthquakes often result in the spread of diseases like gastroenteritis, giardiasis and even cholera because of an immediate shortage of clean drinking water. Now, chemistry researchers at McGill University have taken a key step towards making a cheap, portable, paper-based filter coated with silver nanoparticles to be used in these emergency settings.
A study appearing in this week's New England Journal of Medicine confirms that a combination of gene variants previously associated with cholesterol levels does reflect patients' cholesterol levels and can signify increased risk of heart attack, stroke or sudden cardiac death.
The emergency rooms at the CHU Sainte-Justine and The Montreal Children's Hospital of the McGill University Health Centre are seeing a significant increase in patients seeking care. The increase is due to patients with mild flu-like symptoms and fever and due to parents asking that their child be tested to determine if he has H1N1.
› Verified 6 days ago
| Provider Name | Candice Siciliano |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1215035472 PECOS PAC ID: 2961846472 Enrollment ID: I20240222002962 |
News Archive
Celtaxsys, Inc., a clinical stage drug development company focused on developing novel therapies for inflammatory diseases, today announced the successful completion of a $40M Series D financing led by Domain Partners VIII. Additional investors in the financing include Lumira Capital, RMI Partners, Masters Capital Management and the Georgia Research Alliance Venture Fund.
Disasters such as floods, tsunamis, and earthquakes often result in the spread of diseases like gastroenteritis, giardiasis and even cholera because of an immediate shortage of clean drinking water. Now, chemistry researchers at McGill University have taken a key step towards making a cheap, portable, paper-based filter coated with silver nanoparticles to be used in these emergency settings.
A study appearing in this week's New England Journal of Medicine confirms that a combination of gene variants previously associated with cholesterol levels does reflect patients' cholesterol levels and can signify increased risk of heart attack, stroke or sudden cardiac death.
The emergency rooms at the CHU Sainte-Justine and The Montreal Children's Hospital of the McGill University Health Centre are seeing a significant increase in patients seeking care. The increase is due to patients with mild flu-like symptoms and fever and due to parents asking that their child be tested to determine if he has H1N1.
› Verified 6 days ago
| Provider Name | Muranda Griggs |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1194269779 PECOS PAC ID: 6406291319 Enrollment ID: I20240301001887 |
News Archive
Celtaxsys, Inc., a clinical stage drug development company focused on developing novel therapies for inflammatory diseases, today announced the successful completion of a $40M Series D financing led by Domain Partners VIII. Additional investors in the financing include Lumira Capital, RMI Partners, Masters Capital Management and the Georgia Research Alliance Venture Fund.
Disasters such as floods, tsunamis, and earthquakes often result in the spread of diseases like gastroenteritis, giardiasis and even cholera because of an immediate shortage of clean drinking water. Now, chemistry researchers at McGill University have taken a key step towards making a cheap, portable, paper-based filter coated with silver nanoparticles to be used in these emergency settings.
A study appearing in this week's New England Journal of Medicine confirms that a combination of gene variants previously associated with cholesterol levels does reflect patients' cholesterol levels and can signify increased risk of heart attack, stroke or sudden cardiac death.
The emergency rooms at the CHU Sainte-Justine and The Montreal Children's Hospital of the McGill University Health Centre are seeing a significant increase in patients seeking care. The increase is due to patients with mild flu-like symptoms and fever and due to parents asking that their child be tested to determine if he has H1N1.
› Verified 6 days ago
| Provider Name | Jiri Biciste |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1023204476 PECOS PAC ID: 6002252376 Enrollment ID: I20240308001210 |
News Archive
Celtaxsys, Inc., a clinical stage drug development company focused on developing novel therapies for inflammatory diseases, today announced the successful completion of a $40M Series D financing led by Domain Partners VIII. Additional investors in the financing include Lumira Capital, RMI Partners, Masters Capital Management and the Georgia Research Alliance Venture Fund.
Disasters such as floods, tsunamis, and earthquakes often result in the spread of diseases like gastroenteritis, giardiasis and even cholera because of an immediate shortage of clean drinking water. Now, chemistry researchers at McGill University have taken a key step towards making a cheap, portable, paper-based filter coated with silver nanoparticles to be used in these emergency settings.
A study appearing in this week's New England Journal of Medicine confirms that a combination of gene variants previously associated with cholesterol levels does reflect patients' cholesterol levels and can signify increased risk of heart attack, stroke or sudden cardiac death.
The emergency rooms at the CHU Sainte-Justine and The Montreal Children's Hospital of the McGill University Health Centre are seeing a significant increase in patients seeking care. The increase is due to patients with mild flu-like symptoms and fever and due to parents asking that their child be tested to determine if he has H1N1.
› Verified 6 days ago
| Provider Name | Kathleen S Lehn |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1518988229 PECOS PAC ID: 2062856891 Enrollment ID: I20240308002792 |
News Archive
Celtaxsys, Inc., a clinical stage drug development company focused on developing novel therapies for inflammatory diseases, today announced the successful completion of a $40M Series D financing led by Domain Partners VIII. Additional investors in the financing include Lumira Capital, RMI Partners, Masters Capital Management and the Georgia Research Alliance Venture Fund.
Disasters such as floods, tsunamis, and earthquakes often result in the spread of diseases like gastroenteritis, giardiasis and even cholera because of an immediate shortage of clean drinking water. Now, chemistry researchers at McGill University have taken a key step towards making a cheap, portable, paper-based filter coated with silver nanoparticles to be used in these emergency settings.
A study appearing in this week's New England Journal of Medicine confirms that a combination of gene variants previously associated with cholesterol levels does reflect patients' cholesterol levels and can signify increased risk of heart attack, stroke or sudden cardiac death.
The emergency rooms at the CHU Sainte-Justine and The Montreal Children's Hospital of the McGill University Health Centre are seeing a significant increase in patients seeking care. The increase is due to patients with mild flu-like symptoms and fever and due to parents asking that their child be tested to determine if he has H1N1.
› Verified 6 days ago
| Provider Name | Desiree Niederer |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1164817169 PECOS PAC ID: 2769828847 Enrollment ID: I20240312000741 |
News Archive
Celtaxsys, Inc., a clinical stage drug development company focused on developing novel therapies for inflammatory diseases, today announced the successful completion of a $40M Series D financing led by Domain Partners VIII. Additional investors in the financing include Lumira Capital, RMI Partners, Masters Capital Management and the Georgia Research Alliance Venture Fund.
Disasters such as floods, tsunamis, and earthquakes often result in the spread of diseases like gastroenteritis, giardiasis and even cholera because of an immediate shortage of clean drinking water. Now, chemistry researchers at McGill University have taken a key step towards making a cheap, portable, paper-based filter coated with silver nanoparticles to be used in these emergency settings.
A study appearing in this week's New England Journal of Medicine confirms that a combination of gene variants previously associated with cholesterol levels does reflect patients' cholesterol levels and can signify increased risk of heart attack, stroke or sudden cardiac death.
The emergency rooms at the CHU Sainte-Justine and The Montreal Children's Hospital of the McGill University Health Centre are seeing a significant increase in patients seeking care. The increase is due to patients with mild flu-like symptoms and fever and due to parents asking that their child be tested to determine if he has H1N1.
› Verified 6 days ago
News Archive
Celtaxsys, Inc., a clinical stage drug development company focused on developing novel therapies for inflammatory diseases, today announced the successful completion of a $40M Series D financing led by Domain Partners VIII. Additional investors in the financing include Lumira Capital, RMI Partners, Masters Capital Management and the Georgia Research Alliance Venture Fund.
Disasters such as floods, tsunamis, and earthquakes often result in the spread of diseases like gastroenteritis, giardiasis and even cholera because of an immediate shortage of clean drinking water. Now, chemistry researchers at McGill University have taken a key step towards making a cheap, portable, paper-based filter coated with silver nanoparticles to be used in these emergency settings.
A study appearing in this week's New England Journal of Medicine confirms that a combination of gene variants previously associated with cholesterol levels does reflect patients' cholesterol levels and can signify increased risk of heart attack, stroke or sudden cardiac death.
The emergency rooms at the CHU Sainte-Justine and The Montreal Children's Hospital of the McGill University Health Centre are seeing a significant increase in patients seeking care. The increase is due to patients with mild flu-like symptoms and fever and due to parents asking that their child be tested to determine if he has H1N1.
› Verified 6 days ago
Compass Counseling, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1236 G St, Anchorage, AK 99501 Phone: 907-317-7136 | |
Buckingham Psychological Services Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2401 E 42nd Ave Ste 306, Anchorage, AK 99508 Phone: 907-744-1882 | |
Jillanne Garrity Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 8721 Kathleen Dr, Anchorage, AK 99502 Phone: 907-312-4448 | |
Sealing Cove Counseling Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 821 N St Ste 102, Anchorage, AK 99501 Phone: 907-312-5564 | |
Frontier Health Services, P.c. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4241 B Street, Suite 305, Anchorage, AK 99503 Phone: 907-222-6688 Fax: 800-556-6916 | |
Building Blocks Academy Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3327 Fairbanks St, Anchorage, AK 99503 Phone: 907-331-8598 | |
Volunteers Of America Alaska, Russian Jack Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4300 E 20th Ave, Anchorage, AK 99508 Phone: 907-279-9640 |